Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry-Reference-Cited by-同舟云学术

Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry

Published:2006 Issue:4 Volume:68 Page:620-628
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Holzer Ralf,de Giovanni Jo,Walsh Kevin P.,Tometzki Andrew,Goh TH,Hakim Fakhri,Zabal Carlos,de Lezo Jose Suarez,Cao Qi-Ling,Hijazi Ziyad M.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference22 articles.

1. . Ventricular septal defects. In: , , , editors. Heart Disease in Infants, Children and Adolescents. Philadelphia: Lippincott Williams & Wilkins; 2001. pp 636–651.

2. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial.

3. Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

4. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device

5. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: Technical and morphological considerations

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Word of caution: silent late device embolisation after perimembranous ventricular septal defect closure in a 6-Kg infant;Cardiology in the Young;2024-01-03

2. Occlusion Devices for Cardiovascular Disease;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

3. Pediatric Catheter Intervention;Pediatric Cardiology;2024

4. Transcatheter Ventricular Septal Defect Closure with Lifetech™ Konar-MF Occluder in Infants Under 10 kg with Only Using Venous Access;Pediatric Cardiology;2023-12-11

5. Incidence, Risk Factors, and Outcomes of Conduction Disturbances After Percutaneous Closure of Perimembranous Ventricular Septal Defects in Children and Adolescents: A Mid-term Follow-up;Iranian Journal of Pediatrics;2023-09-15